Alyeska Investment Group’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-150,000	Closed	-$3.28M	–	554
2025 Q1	$3.28M	Buy	+150,000	New	+$3.28M	0.01%	386
2023 Q3	–	Sell	-50,000	Closed	-$4.56M	–	474
2023 Q2	$4.56M	Buy	+50,000	New	+$4.56M	0.03%	330